Compare ECO & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ECO | LENZ |
|---|---|---|
| Founded | 2018 | 2019 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 278.4M |
| IPO Year | 2023 | 2021 |
| Metric | ECO | LENZ |
|---|---|---|
| Price | $54.08 | $7.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $42.00 | ★ $44.00 |
| AVG Volume (30 Days) | 395.4K | ★ 857.4K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | ★ 6.12% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,088,000.00 |
| Revenue This Year | $16.07 | $50.42 |
| Revenue Next Year | N/A | $197.16 |
| P/E Ratio | $18.60 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $21.27 | $6.61 |
| 52 Week High | $58.45 | $50.19 |
| Indicator | ECO | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 49.68 | 40.18 |
| Support Level | $52.70 | N/A |
| Resistance Level | $57.87 | $10.42 |
| Average True Range (ATR) | 2.22 | 0.65 |
| MACD | -0.29 | -0.09 |
| Stochastic Oscillator | 23.48 | 25.19 |
Okeanis Eco Tankers Corp is an international owner and operator of a fleet of tanker vessels used for the transportation of crude oil. Its fleet consists of modern Suezmax and VLCC tankers that are designed in accordance with eco-efficiency standards, including features such as reduced fuel consumption, exhaust gas cleaning systems, and ballast water treatment systems. All of the company's revenue is derived from a single segment, the crude oil tanker segment. Geographically, the maximum revenue is generated from Europe, and the rest from Asia, North America, and South America.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.